Obesity study: Eloralintide
Official title A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
ClinicalTrials.gov ID: NCT07321886
What this study is testing
What is Eloralintide?
Eloralintide is an investigational injectable medicine being studied as a potential treatment for obesity.
Also referred to as LY3841136.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether eloralintide works well and is safe. It also checks for any side effects.
- Who it's for
- You may be able to join if you are an adult with obesity or overweight. You must not have type 2 diabetes.
- What's involved
- You would take the medicine eloralintide. You would also go to visits for check-ups and tests.
- Time commitment
- The main part lasts about 75 weeks. Some people stay for two more years.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 30 kilogram per square meter (kg/m2) OR
- high blood pressure
- dyslipidemia
- obstructive sleep apnea, or
- heart disease
You likely can't join if
- Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed \>1 year before screening)
- Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was...
- Have type 1 diabetes or type 2 diabetes
- heart attack
- stroke
- coronary artery revascularization
See the full eligibility criteria
- 30 kilogram per square meter (kg/m2) OR
- high blood pressure
- dyslipidemia
- obstructive sleep apnea, or
- heart disease
- Have a stable body weight (\<5% body weight change) for 90 days prior to screening.
- Have a history of at least one self-reported unsuccessful dietary effort to reduce body weight
- Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed \>1 year before screening)
- Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
- Have type 1 diabetes or type 2 diabetes
- heart attack
- stroke
- coronary artery revascularization
- unstable angina, or
- hospitalization due to congestive heart failure
- Have a history or diagnosis of New York Heart Association Functional Classification Class IV congestive heart failure
- Have taken medications or alternative remedies intended for weight loss within 90 days of screening
The study team makes the final eligibility decision.
Where it is enrolling
- Tuscaloosa, Alabama, United States
- Scottsdale, Arizona, United States
- Escondido, California, United States
- Fountain Valley, California, United States
- Palm Springs, California, United States
- Rolling Hills Estates, California, United States
- Sacramento, California, United States
- Santa Ana, California, United States
- Tustin, California, United States
- Waterbury, Connecticut, United States
- Atlantis, Florida, United States
- Miami, Florida, United States
- Mt. Dora, Florida, United States
- Pembroke Pines, Florida, United States
- Pensacola, Florida, United States
- St. Petersburg, Florida, United States
- Dunwoody, Georgia, United States
- Lawrenceville, Georgia, United States
- Stockbridge, Georgia, United States
- Honolulu, Hawaii, United States
+ 95 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tuscaloosa, Alabama, United States; Scottsdale, Arizona, United States; Escondido, California, United States; Fountain Valley, California, United States; Palm Springs, California, United States; Rolling Hills Estates, California, United States and 109 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.